v3.26.1
Consolidated Statements of Cash Flows - COP ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income before income tax of continuing operations $ 4,621,234 $ 3,107,791 $ 3,423,181
Reconciliation of net income before taxes and net cash provided by operating activities      
Depreciation of tangible assets and right-of-use assets 597,897 561,845 531,401
Amortization of intangible assets 767,850 674,335 579,967
Impairment losses on loans and other accounts receivable 4,324,724 4,686,752 4,647,047
Net interest income (7,871,331) (6,927,411) (5,895,250)
Accrued dividends (126,700) (141,867) (119,988)
Net gains on sales of non-current assets held for sale (9,945) (18,107) (45,624)
Gain on sale of property plant and equipment for own-use and operating lease (131,863) (75,275) (345,330)
Loss on sale of investment property 28,392 14,398 22,177
Gain on sale biological assets (5,152) (9,377) (10,467)
Valuations and interest from concession agreements (2,807,293) (2,850,244) (3,916,465)
Foreign exchange (gains) losses (584,990) 452,635 (2,253,880)
Profit of equity accounted on investments in associates and joint ventures (350,935) (378,396) (371,397)
Net (gains) or losses on fair value adjustments:      
Derivatives 257,762 (415,640) 2,581,265
Non-current assets held for sale 1,622 4,662 70
Investment properties (68,306) (36,705) (92,607)
Biological assets (3,396) (7,589) (18,601)
Changes in operating assets and liabilities      
Trading assets (6,792,442) (5,570,819) (2,778,438)
Accounts receivable (892,411) (792,468) (1,152,043)
Derivatives (550,854) 238,494 (2,091,188)
Other assets (6,697) (137,978) (101,390)
Other liabilities and provisions 2,732,480 1,096,914 1,477,567
Employee benefits (12,865) 51,048 (19,461)
Loans (17,695,997) (13,161,784) (7,710,154)
Customer deposits 24,820,228 14,344,651 14,085,593
Interbank borrowings and overnight funds 4,927,947 2,766,952 6,221,968
Borrowings from banks and others 931,791 (1,019,921) (799,439)
Interest received 23,419,517 26,797,798 24,853,524
Interest paid (17,720,295) (20,488,941) (20,636,834)
Interest paid on leases (237,774) (236,451) (198,436)
Income tax paid (2,163,430) (1,998,655) (1,967,389)
Discontinued operation (2,013,798) 251,642 (1,893,878)
Net cash provided by operating activities 7,384,970 782,289 6,005,501
Cash flows from investing activities:      
Acquisition of property, plant and equipment for own use and operating lease (602,321) (623,876) (579,583)
Acquisition of investment property (8,263) (793) (163)
Additions of cost of biological assets (27,222) (26,572) (26,118)
Concession contracts 158,772 305,686 853,778
Additions of others intangibles assets (660,286) (652,681) (676,765)
Acquisition of investments at FVOCI (17,451,317) (14,655,069) (23,754,394)
Proceeds from sale of investments at FVOCI 13,675,934 11,643,956 24,824,898
Proceeds from sale of own-use property and equipment and operating lease 152,445 76,963 68,523
Proceeds from sale of investment properties 207,927 66,358 111,542
Proceeds from sale of biological assets 38,700 35,871 37,144
Proceeds from sale of non-current assets held for sale 75,178 37,856 49,369
Purchases of financial assets at amortized cost (7,015,566) (7,801,052) (8,009,518)
Redemptions of financial assets at amortized cost 8,685,569 8,217,845 8,144,359
Dividends received from investments 444,386 439,017 471,282
Acquisition of investments in associates   (2,486) (2,433)
Capitalized leasing cost (282) (335) (132)
Deconsolidation of entities     (2,290)
Discontinued operation 895,588 (202,561) 331,148
Net cash (used in) provided by investing activities (1,430,758) (3,141,873) 1,840,647
Cash flows from financing activities:      
Dividends paid to shareholders (625,826) (728,181) (766,537)
Dividends paid to non-controlling interest (662,266) (667,330) (915,933)
Issuance of debt securities 528,863 2,224,164 1,111,819
Payment of outstanding debt securities (1,513,644) (1,725,323) (3,934,469)
Payment of obligations under financial lease (429,493) (409,118) (384,499)
Equity transaction (6) (55,000)  
Discontinued operation 37,780 (2,223) 1,352,734
Net cash used in financing activities (2,664,592) (1,363,011) (3,536,885)
Effect of foreign currency changes on cash and cash equivalents (1,334,867) 2,123,593 (2,744,460)
Cash and cash equivalents from non-current assets classified as held for sale 401,098   201
Increase (decrease) in cash and cash equivalents from continuing operations 2,355,851 (1,599,002) 1,565,004
Cash and cash equivalents at beginning of year 16,998,859 18,597,861 17,032,857
Cash and cash equivalents at end of year $ 19,354,710 $ 16,998,859 $ 18,597,861